1. Home
  2. GGRP vs INTS Comparison

GGRP vs INTS Comparison

Compare GGRP & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Glimpse Group Inc. Common Stock

GGRP

The Glimpse Group Inc. Common Stock

N/A

Current Price

$0.82

Market Cap

11.8M

Sector

Technology

ML Signal

N/A

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$3.62

Market Cap

12.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GGRP
INTS
Founded
2016
2012
Country
United States
United States
Employees
40
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
12.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
GGRP
INTS
Price
$0.82
$3.62
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$38.00
AVG Volume (30 Days)
267.4K
23.8K
Earning Date
05-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$72.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.42
$0.19
52 Week High
$0.94
$8.06

Technical Indicators

Market Signals
Indicator
GGRP
INTS
Relative Strength Index (RSI) 63.25 17.17
Support Level $0.47 $0.31
Resistance Level $0.94 $8.06
Average True Range (ATR) 0.08 0.22
MACD -0.00 -0.04
Stochastic Oscillator 77.61 12.80

Price Performance

Historical Comparison
GGRP
INTS

About GGRP The Glimpse Group Inc. Common Stock

The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc . is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Share on Social Networks: